Skip to main content
OpenTrials
Completed

NCT Number: NCT03814044

PMCF Study on PEEK Suture Anchors for Hip Indications

Post-market clinical follow-up (PMCF) on the PEEK Suture Anchors in the hip.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Soft Tissue to Bone Fixation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

DMOS Orthopedic Centers, West Des Moines, Iowa, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects who have undergone hip joint repair using the study devices.
  • Subjects aged 18 years and older at the time of surgery.
  • Subjects who had a visit to their provider between 3 and 15 months postoperative.

Exclusion criteria

  • Subjects who are < 12 months post-operative.
  • Subject is entered in another investigational drug, biologic, or device study or has been treated with an investigational product within 30 days prior to surgery
  • Subject had off-label use of the PEEK suture anchor during surgery.

Treatment and study plan

PEEK Suture Anchors

Device

Subjects who have undergone hip joint repair using PEEK Suture Anchors:

BIORAPTOR™ Knotless Suture Anchor and SpeedLock Hip Suture Anchor

Primary outcomes

  1. Number of Participants With Clinical Success of the Study Devices in the Hip Over a Time Period of 6 Months After Intervention

    Time frame: 6 months

    Clinical success was defined as hip repairs without signs of device failure and/or re-intervention as assessed by the surgeon (Yes/No). Specifically, clinical success was achieved with "Yes" responses on the following 3 main criteria:

    • no inflammatory or allergic response
    • no device-related adverse event (AE)
    • no device deficiencies (DDs) leading to revision surgery (reintervention) on the index hip

Secondary outcomes

  1. Number of Participants With Clinical Success of the Study Devices in the Hip Over a Time Period of 12 Months After Intervention

    Time frame: 12 months

    Clinical success was defined as hip repairs without signs of device failure and/or re-intervention as assessed by the surgeon (Yes/No). Specifically, clinical success was achieved with "Yes" responses on the following 3 main criteria:

    • no inflammatory or allergic response
    • no device-related adverse event (AE)
    • no device deficiencies (DDs) leading to revision surgery (reintervention) on the index hip

  2. Visual Analog Scale (VAS) - Pain

    Time frame: 6 and 12 months

    The VAS pain score is presented on a scale ranging from 0 to 10. A score of 0 represents no pain and a score of 10 indicates extreme/unbearable pain. The VAS rating was recorded retrospectively, per standard of care at 6 and 12 months post-surgery.

  3. Count of Participants With Range of Motion (ROM) Full Functional Arc

    Time frame: 6 months and 12 months

    Range of motion defined as the participant having a full functional arc "Yes" or "No" at 6 month and 12 month post-operative visits.

  4. Range of Motion (ROM)

    Time frame: 6 and 12 months

    Forward flexion angle, internal rotation angle, and external rotation angle captured in degrees based on the physician's Standard of Care.

Sponsors and collaborators

Lead sponsor

Smith & Nephew, Inc.

Industry

Registry information

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Jan 23, 2019
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.